NM Coordinating Committee: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
:Chairs: | :Chairs: P. David Mozley, MD (Co-chair), John J.Sunderland, PhD (Co-chair), Anne Smith, PhD (Vice-chair) | ||
:RSNA Staff Support: Julie Lisiecki | :RSNA Staff Support: Julie Lisiecki | ||
Revision as of 18:40, 25 September 2019
- Chairs: P. David Mozley, MD (Co-chair), John J.Sunderland, PhD (Co-chair), Anne Smith, PhD (Vice-chair)
- RSNA Staff Support: Julie Lisiecki
Scope
The NM Coordinating Committee coordinates Biomarker Committees based on NM.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page coming soon]
- I-123 Biomarker Committee [page coming soon]
Meetings
- WebEx calls are held Quarterly. Please contact RSNA Staff for details.